5 6 Doctor Will's Limited 09965620 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is Other Food Services Digita Accounts Production Advanced 6.30.9574.0 true 09965620 2025-01-01 2025-12-31 09965620 2025-12-31 09965620 core:CurrentFinancialInstruments 2025-12-31 09965620 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 09965620 core:Non-currentFinancialInstruments 2025-12-31 09965620 core:Non-currentFinancialInstruments core:AfterOneYear 2025-12-31 09965620 core:PlantMachinery 2025-12-31 09965620 bus:SmallEntities 2025-01-01 2025-12-31 09965620 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 09965620 bus:FilletedAccounts 2025-01-01 2025-12-31 09965620 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 09965620 bus:RegisteredOffice 2025-01-01 2025-12-31 09965620 bus:CompanySecretaryDirector1 2025-01-01 2025-12-31 09965620 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 09965620 countries:EnglandWales 2025-01-01 2025-12-31 09965620 2024-12-31 09965620 core:PlantMachinery 2024-12-31 09965620 2024-01-01 2024-12-31 09965620 2024-12-31 09965620 core:CurrentFinancialInstruments 2024-12-31 09965620 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 09965620 core:Non-currentFinancialInstruments 2024-12-31 09965620 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 xbrli:pure iso4217:GBP

Registration number: 09965620

Doctor Will's Limited
Unaudited Filleted Financial Statements
for the Year Ended 31 December 2025

Doctor Will's Limited

(Registration number: 09965620)
Statement of Financial Position as at 31 December 2025

| Note | 2025 £ | 2024 £
Current assets |  |  |
Stocks | 5 | 226,759 | 155,757
Debtors | 6 | 159,003 | 40,349
Cash at bank and in hand |  | 88,178 | 48,968
|  | 473,940 | 245,074
Creditors: Amounts falling due within one year | 7 | (837,624) | (417,579)
Total assets less current liabilities |  | (363,684) | (172,505)
Creditors: Amounts falling due after more than one year | 7 | (224,500) | (416,396)
Net liabilities |  | (588,184) | (588,901)
Capital and reserves |  |  |
Called up share capital |  | 435 | 378
Share premium reserve |  | 4,040,647 | 3,301,828
Retained earnings |  | (4,629,266) | (3,891,107)
Shareholders' deficit |  | (588,184) | (588,901)

Doctor Will's Limited

(Registration number: 09965620)
Statement of Financial Position as at 31 December 2025

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Income Statement.

Approved and authorised by the Board on 5 February 2026 and signed on its behalf by:

......................................... Mr R W Breakey Company secretary and director

Doctor Will's Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
46 High Street
Gosforth
Newcastle Upon Tyne
Tyne & Wear
NE3 1LX

These financial statements were authorised for issue by the Board on 5 February 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.
Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Doctor Will's Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

3 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 5 (2024 - 6).

Doctor Will's Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

4 | Tangible assets

| Plant and machinery £ | Total £
Cost or valuation
At 1 January 2025 | 34,031 | 34,031
At 31 December 2025 | 34,031 | 34,031
Depreciation
At 1 January 2025 | 34,031 | 34,031
At 31 December 2025 | 34,031 | 34,031
Carrying amount
At 31 December 2025 | - | -

5 | Stocks

| 2025 £ | 2024 £
Finished goods and goods for resale | 226,759 | 155,757

6 | Debtors

Current | 2025 £ | 2024 £
Trade debtors | 132,313 | 29,237
Prepayments | 12,713 | 5,050
Other debtors | 13,977 | 6,062
| 159,003 | 40,349

Doctor Will's Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

7 | Creditors

Creditors: amounts falling due within one year

| Note | 2025 £ | 2024 £
Due within one year |  |  |
Loans and borrowings | 8 | 363,037 | 204,960
Trade creditors |  | 238,883 | 140,089
Taxation and social security |  | 9,753 | 7,231
Accruals and deferred income |  | 10,034 | 4,528
Other creditors |  | 215,917 | 60,771
|  | 837,624 | 417,579

Creditors: amounts falling due after more than one year

| Note | 2025 £ | 2024 £
Due after one year |  |  |
Loans and borrowings | 8 | 224,500 | 416,396

8 | Loans and borrowings

Non-current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | - | 4,396
Other borrowings | 224,500 | 412,000
| 224,500 | 416,396

Current loans and borrowings

| 2025 £ | 2024 £
Bank borrowings | 4,399 | 9,886
Bank overdrafts | 52,503 | 7,574
Other borrowings | 306,135 | 187,500
| 363,037 | 204,960